Results 161 to 170 of about 85,655 (308)
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. [PDF]
Umyarova E +8 more
europepmc +1 more source
Successful Multimodal Therapeutic Approach for CD30‐positive Folliculotropic Mycosis Fungoides
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Chiara L. Blomen +5 more
wiley +1 more source
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster +68 more
wiley +1 more source
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Report of three cases. [PDF]
Vargas-Mora P +5 more
europepmc +1 more source
Mapping malignant T‐cell states and immune circuits in Sézary syndrome by single‐cell analysis
Peripheral blood single‐cell RNA‐seq from leukaemic CTCL defined three malignant T‐cell programmes: MTC CM, MTC Reg and MTC E/EM, each with distinct features and candidate vulnerabilities. For example, inferred immune circuits highlighted actionable IL‐10/JAK–TYK2–STAT3 signalling, KIR–MHC I inhibitory interactions and myeloid/B‐cell inflammatory and ...
Beth A. Childs +6 more
wiley +1 more source
Pathology of Cutaneous T Cell Lymphoma: A Narrative Review. [PDF]
Zhang T +6 more
europepmc +1 more source
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore +8 more
wiley +1 more source
Case Report: When syphilis imitates cancer: a case of misdiagnosed cutaneous T-cell lymphoma. [PDF]
Giordano U +5 more
europepmc +1 more source

